Regional Excellence for Access to Comprehensive Care for Hemophilia Networks (REACH Networks)
Forecast
Health Resources and Services Administration plans to offer grants of up to $450,000 (at least $450,000) to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expects to make about 8 awards worth $3.6 million in total. It is a forecast: the notice is expected around November 6, 2026, with applications due around December 22, 2026.
From the official notice on Grants.gov, last changed August 24, 2026. Checked October 31, 2026.
- Award ceiling$450,000
- Award floor$450,000
- Expected awards8
- Total funding$3.6 million
- Cost sharingNot required
- Funding typeGrant
Key dates
| Forecast posted | August 24, 2026 |
|---|---|
| Expected posting | November 6, 2026 |
| Expected deadline | December 22, 2026 |
| Expected award date | May 2, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. § 450b) is eligible to apply. See 42 CFR § 51a.3(a).
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The purpose of the Regional Excellence for Access to Comprehensive Care for Hemophilia Networks (REACH Networks) is to improve access to coordinated evidence-based comprehensive care for individuals with hemophilia and other related bleeding and clotting disorders. This program will expand access to comprehensive care, conduct quality improvement projects, train the workforce, provide ongoing education to Hemophilia Treatment Center staff, improve best practices for comprehensive and collaborative care including lifespan transitions.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to DSCSHN - REACH, cyshcn@hrsa.gov, 301-443-5962.
Questions people ask
Who can apply for Regional Excellence for Access to Comprehensive Care for Hemophilia Networks (REACH Networks)?
Health Resources and Services Administration accepts applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Regional Excellence for Access to Comprehensive Care for Hemophilia Networks (REACH Networks)?
Expected deadline December 22, 2026. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $450,000 each. About $3.6 million in total across about 8 awards.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience